Vista Pharmaceuticals Limited (VISTAPH.BO)
INR 11.08
(2.12%)
INR 11.08
(2.12%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.96 INR | 37.66% |
| 2022 | -1.54 INR | -541.67% |
| 2021 | -0.24 INR | 58.62% |
| 2020 | -0.58 INR | 52.07% |
| 2019 | -1.21 INR | -490.32% |
| 2018 | 0.31 INR | -59.21% |
| 2017 | 0.76 INR | 65.22% |
| 2016 | 0.46 INR | 48.39% |
| 2015 | 0.31 INR | -42.59% |
| 2014 | 0.54 INR | 74.19% |
| 2013 | 0.31 INR | 520.0% |
| 2012 | 0.05 INR | 104.5% |
| 2011 | -1.11 INR | -484.21% |
| 2010 | -0.19 INR | 78.16% |
| 2009 | -0.87 INR | -29.85% |
| 2008 | -0.67 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.15 INR | -850.0% |
| 2023 Q3 | -0.35 INR | 23.91% |
| 2023 FY | - INR | 37.66% |
| 2023 Q4 | 0.02 INR | 105.71% |
| 2023 Q2 | -0.46 INR | -109.09% |
| 2023 Q1 | -0.22 INR | 78.64% |
| 2022 Q3 | -0.26 INR | -225.0% |
| 2022 FY | - INR | -541.67% |
| 2022 Q4 | -1.03 INR | -296.15% |
| 2022 Q2 | -0.08 INR | 55.56% |
| 2022 Q1 | -0.18 INR | -250.0% |
| 2021 Q2 | -0.60 INR | -1900.0% |
| 2021 FY | - INR | 58.62% |
| 2021 Q4 | 0.12 INR | 170.59% |
| 2021 Q1 | -0.03 INR | 63.46% |
| 2021 Q3 | -0.17 INR | 71.67% |
| 2020 Q4 | -0.08 INR | 36.85% |
| 2020 FY | - INR | 52.07% |
| 2020 Q1 | -0.48 INR | 60.33% |
| 2020 Q2 | 0.11 INR | 122.92% |
| 2020 Q3 | -0.13 INR | -218.18% |
| 2019 Q3 | -0.07 INR | -333.33% |
| 2019 Q4 | -1.21 INR | -1628.57% |
| 2019 FY | - INR | -490.32% |
| 2019 Q1 | 0.03 INR | -86.36% |
| 2019 Q2 | 0.03 INR | 0.0% |
| 2018 Q4 | 0.22 INR | 633.33% |
| 2018 FY | - INR | -59.21% |
| 2018 Q2 | 0.03 INR | -25.0% |
| 2018 Q1 | 0.04 INR | -80.0% |
| 2018 Q3 | 0.03 INR | 0.0% |
| 2017 Q2 | 0.21 INR | 40.0% |
| 2017 FY | - INR | 65.22% |
| 2017 Q4 | 0.20 INR | -4.76% |
| 2017 Q3 | 0.21 INR | 0.0% |
| 2017 Q1 | 0.15 INR | 200.0% |
| 2016 Q1 | 0.13 INR | -63.89% |
| 2016 Q4 | 0.05 INR | -70.59% |
| 2016 Q3 | 0.17 INR | 21.43% |
| 2016 Q2 | 0.14 INR | 7.69% |
| 2016 FY | - INR | 48.39% |
| 2015 Q4 | 0.36 INR | 173.47% |
| 2015 FY | - INR | -42.59% |
| 2015 Q1 | -0.20 INR | -233.33% |
| 2015 Q2 | -0.48 INR | -140.0% |
| 2015 Q3 | -0.49 INR | -2.08% |
| 2014 Q4 | 0.15 INR | -67.39% |
| 2014 FY | - INR | 74.19% |
| 2014 Q1 | 0.19 INR | -63.46% |
| 2014 Q2 | 0.14 INR | -26.32% |
| 2014 Q3 | 0.46 INR | 228.57% |
| 2013 Q1 | -0.20 INR | -1134.57% |
| 2013 FY | - INR | 520.0% |
| 2013 Q4 | 0.52 INR | 244.44% |
| 2013 Q3 | -0.36 INR | -3700.0% |
| 2013 Q2 | 0.01 INR | 105.0% |
| 2012 Q1 | 0.02 INR | 0.0% |
| 2012 FY | - INR | 104.5% |
| 2012 Q4 | -0.02 INR | -262.0% |
| 2012 Q3 | 0.01 INR | -83.33% |
| 2012 Q2 | 0.06 INR | 200.0% |
| 2011 FY | - INR | -484.21% |
| 2011 Q3 | -0.29 INR | 0.0% |
| 2011 Q4 | - INR | 100.0% |
| 2010 FY | - INR | 78.16% |
| 2010 Q4 | 0.10 INR | 0.0% |
| 2009 Q4 | -0.30 INR | 0.0% |
| 2009 FY | - INR | -29.85% |
| 2008 Q4 | -0.30 INR | 0.0% |
| 2008 FY | - INR | 0.0% |